Klaus Pamminger - GrainCorp Group General Manager of Marketing
GRCLF Stock | USD 4.92 0.28 5.38% |
Executive
Mr. Klaus Pamminger is Chief Operating Officer of the Company. He was Group General Manager GrainCorporationMarketing of the Company, since August 2012. He is responsible for the Grains Operations and Trading businesses in Australia, Singapore, China, Europe and Canada. Mr. Pamminger joined GrainCorporationin 2007 and prior to this he worked for a number of companies in Australia and the US since 2019.
Tenure | 5 years |
Phone | 61 2 9325 9100 |
Web | https://www.graincorp.com.au |
GrainCorp Management Efficiency
The company has return on total asset (ROA) of 0.2022 % which means that it generated a profit of $0.2022 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2863 %, meaning that it generated $0.2863 on every $100 dollars invested by stockholders. GrainCorp's management efficiency ratios could be used to measure how well GrainCorp manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Steven Vontur | Intuitive Machines | N/A | |
Matthew Morgenroth | Wilmar International | N/A | |
Pedy Harianto | Golden Agri Resources | N/A | |
Peter II | Intuitive Machines | 56 | |
BSc MD | Aerovate Therapeutics | N/A | |
David Hallett | Recursion Pharmaceuticals | 55 | |
Janelle Gordon | Recursion Pharmaceuticals | N/A | |
Anna Jones | Intuitive Machines | 44 | |
William George | Sprott Focus Trust | 66 | |
Jade Marcantel | Intuitive Machines | N/A | |
Michael Ellis | Rumble Inc | 39 | |
Marinus Verwijs | Aerovate Therapeutics | 48 | |
Alon Yaari | InMode | N/A | |
Sanjeev Khindri | Aerovate Therapeutics | N/A | |
Rahul Kale | Wilmar International | N/A | |
Kok Tan | Wilmar International | 49 | |
Mario Aguirre | Brasilagro Adr | 50 | |
Paul Hickman | Golden Agri Resources | 57 | |
LaMei Teo | Wilmar International | 63 | |
Kristen MBA | Recursion Pharmaceuticals | N/A | |
Nathan Hatfield | Recursion Pharmaceuticals | N/A |
Management Performance
GrainCorp Limited Leadership Team
Elected by the shareholders, the GrainCorp's board of directors comprises two types of representatives: GrainCorp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GrainCorp. The board's role is to monitor GrainCorp's management team and ensure that shareholders' interests are well served. GrainCorp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GrainCorp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Cate Hathaway, Interim Group General Manager Human Resources and SHE | ||
Jesse Scott, Chief Officer | ||
Robert BE, MD CEO | ||
LLB BCom, Group Sec | ||
Luke Thrum, Sr Relations | ||
Klaus Pamminger, Group General Manager of Marketing | ||
MBA LLB, Group Officer | ||
Ian Morrison, Chief Officer |
GrainCorp Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is GrainCorp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.29 | |||
Return On Asset | 0.2 | |||
Profit Margin | 0.05 % | |||
Operating Margin | 0.12 % | |||
Current Valuation | 1.75 B | |||
Shares Outstanding | 223.65 M | |||
Shares Owned By Insiders | 1.95 % | |||
Shares Owned By Institutions | 37.37 % | |||
Price To Earning | 5.02 X | |||
Price To Book | 1.22 X |
Currently Active Assets on Macroaxis
Other Information on Investing in GrainCorp Pink Sheet
GrainCorp financial ratios help investors to determine whether GrainCorp Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GrainCorp with respect to the benefits of owning GrainCorp security.